Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: A 3-year randomized, placebo-controlled study

Bjørn Richelsen, Serena Tonstad, Stephan Rössner, Søren Toubro, Leo Niskanen, Steen Madsbad, Pertti Mustajoki, Aila Rissanen

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)27-32
Number of pages6
JournalDiabetes Care
Volume30
Issue number1
DOIs
StatePublished - Jan 2007
Externally publishedYes

ASJC Scopus Subject Areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Keywords

  • Body Mass Index
  • Glucose Intolerance/complications
  • Body Size
  • Humans
  • Middle Aged
  • Male
  • Combined Modality Therapy
  • Diabetes Complications/blood
  • Diet, Reducing
  • Lactones/therapeutic use
  • Anti-Obesity Agents/therapeutic use
  • Obesity/complications
  • Orlistat
  • Placebos
  • Adult
  • Female
  • Weight Gain/drug effects
  • Aged

Cite this